A polyester with hyperbranched architecture as potential nano-grade antibiotics: An in-vitro study

Cytocompatible Hyperbranched Polyesters Capable of Altering the Ca2+ Signaling in Neuronal Cells In Vitro

Synthetic hyperbranched polyesters with potential therapeutic properties were synthesized using the bifunctional polyethylene glycol or PEG with different molecular weights, ca., 4000, 6000, and 20,000 g/mol, and the trifunctional trans-aconitic acid or TAA. During polycondensation, a fixed amount of PEG was allowed to react with varying amounts of TAA (1:1 and 1:3) to control the branching extents. It was found that the synthetic polyesters had a considerable yield and were highly water soluble. Spectroscopic data (Fourier transform infrared and 1H NMR) confirmed the polyester formation; the branching percentages were determined from 1H NMR spectroscopy which varied from 73% to 22% among the synthesized samples. As the molecular weight of PEG was increased, the branching percentage drastically dropped. All polyesters were found to be negatively charged due to the ionization of unreacted -COOH in the branched ends at the working pH (7.4). Both the hydrodynamic size and intrinsic viscosity were found to reduce as the branching extent increased. Among the sets of polyesters, the one with the highest branching percentage (73%) showed the core-shell morphology (evident from field emission scanning electron microscopy and transmission electron microscopy studies). It also exhibited the highest efficiency toward Ca2+ influx in neuronal cells due to the unique morphology and the negatively charged surface. Nevertheless, this particular grade of polyester along with all the other grades was cytocompatible and induced reactive oxygen species generation. Since the maximally branched grade was highly efficient in altering the Ca2+ signaling through stronger influx, it may well be tested for treating neuronal disorders in vivo in future.

Cartilage-targeting poly(ethylene glycol) (PEG)-formononetin (FMN) nanodrug for the treatment of osteoarthritis

Intra-articular (IA) injection is an efficient treatment for osteoarthritis, which will minimize systemic side effects. However, the joint experiences rapid clearance of therapeutics after intra-articular injection. Delivering system modified through active targeting strategies to facilitate localization within specific joint tissues such as cartilage is hopeful to increase the therapeutic effects. In this study, we designed a nanoscaled amphiphilic and cartilage-targeting polymer-drug delivery system by using formononetin (FMN)-poly(ethylene glycol) (PEG) (denoted as PCFMN), which was prepared by PEGylation of FMN followed by coupling with cartilage-targeting peptide (CollBP). Our results showed that PCFMN was approximately regular spherical with an average diameter about 218 nm. The in vitro test using IL-1β stimulated chondrocytes indicated that PCFMN was biocompatible and upregulated anabolic genes while simultaneously downregulated catabolic genes of the articular cartilage. The therapeutic effects in vivo indicated that PCFMN could effectively attenuate the progression of OA as evidenced by immunohistochemical staining and histological analysis. In addition, PCFMN showed higher intention time in joints and better anti-inflammatory effects than FMN, indicating the efficacy of cartilage targeting nanodrug on OA. This study may provide a reference for clinical OA therapy.